A Phase I Study of Oral BGJ398 in Asian Patients

Clinical trial NCT01697605 · COMPLETED

Trial details

NCT number: NCT01697605
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Tumor With Alterations of the FGF-R

Start date: 2012-10-19
Primary completion: 2019-02-07
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.